登录 | 注册    关注公众号  
微信公众号
搜索
 >  Protein>BTK >BTK-H55H3

Human BTK Protein, His Tag (active enzyme)

分子别名(Synonym)

AGMX1, ATK, BPK

表达区间及表达系统(Source)

Human BTK Protein, His Tag (BTK-H55H3) is expressed from Baculovirus-Insect cells. It contains AA Met 1 - Ser 659 (Accession # Q06187-1).

Predicted N-terminus: Met 1

Request for sequence

蛋白结构(Molecular Characterization)

BTK Structure

This protein carries a polyhistidine tag at the C-terminus.

The protein has a calculated MW of 78.2 kDa. The protein migrates as 55 kDa,65 kDa and 85-95 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

内毒素(Endotoxin)

Less than 1.0 EU per μg by the LAL method.

纯度(Purity)

>90% as determined by SDS-PAGE.

制剂(Formulation)

Supplied as 0.2 μm filtered solution in 50 mM Tris, 150 mM NaCl, pH7.5 with glycerol as protectant.

Contact us for customized product form or formulation.

运输(Shipping)

This product is supplied and shipped with dry ice, please inquire the shipping cost.

存储(Storage)

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. The product MUST be stored at -70°C or lower upon receipt;
  2. -70°C for 3 months under sterile conditions.
 

电泳(SDS-PAGE)

BTK SDS-PAGE

Human BTK Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

 

活性(Bioactivity)

The BTK assay is performed using the ADP-GloTM Kinase Assay kit which quantifies the amount of ADP produced by the BTK reaction. The ADP- GloTM Reagent is added to terminate the kinase reaction and to deplete the remaining ATP, and then the Kinase Detection Reagent is added to convert ADP to ATP and to measure the newly synthesized ATP using luciferase/luciferin reaction.The specific activity is >25 pmol/min/ug (QC tested).

Protocol

 

背景(Background)

The protein encoded by this gene plays a crucial role in B-cell development. Mutations in this gene cause X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
BTK靶点信息
英文全称:Tyrosine-protein kinase BTK
中文全称:酪氨酸蛋白激酶BTK
种类:
上市药物数量:6详情
临床药物数量:64详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细
相关产品
View All BTK

消息提示

请输入您的联系方式,再点击提交!

确定